Controlled substance agreement (CSA) enrollment was associated with reductions in primary care visits and increased radiologic service utilization in patients receiving long-term opioid therapy for chronic noncancer pain, a recent study found. Researchers retrospectively evaluated health care utilization changes among patients enrolled in a CSA between July 1, 2015, and December 31, 2015. Patient characteristics and utilization was assessed 12 months before and after CSA enrollment. They found:
- 772 patients (mean age 63.5 years, mostly white, female, married) were enrolled in an opioid CSA during the study period.
- CSA enrollment was associated with decreased outpatient primary care visits and increased diagnostic radiology services.
- Patients with greater comorbidity were more likely to have reductions in hospitalization, outpatient primary care visits, and reduced specialty care visits.
Philpot LM, Ramar P, Elrashidi MY, Sinclair TA, Ebbert JO. A before and after analysis of health care utilization by patients enrolled in opioid controlled substance agreements for chronic noncancer pain. [Published online ahead of print September 20, 2018]. Mayo Clin Proc. doi:10.1016/j.mayocp.2018.05.008.
This Week's Must Reads
Must Reads in Addiction Medicine
Acute Illness and Cannabis Use in Adults, Ann Intern Med; ePub 2019 Mar 26; Monte, et al
Dual Receipt of Rx Opioids & Overdose Death, Ann Intern Med; ePub 2019 Mar 12; Moyo, et al
Opioid-Related Mortality in US by Opioid Type, JAMA Netw Open; 2019 Feb 22; Kiang, et al
Disparities in the Prescription of Opioids, JAMA Intern Med; ePub 2019 Feb 11; Friedman, et al
Prevention of Prescription Opioid Misuse in the US, JAMA Netw Open; 2019 Feb 1; Chen, et al